Geneva, March 20 -- International Clinical Trials Registry received information related to the study (NCT07451054) titled 'CD45BE-HSPC + CART-45 Cells' on Feb. 27.
Study Type: Interventional
Study Design:
Allocation: Non-Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: University of Pennsylvania
Condition:
B-Cell Non-Hodgkin Lymphoma (NHL)
Richter's Transformation
T-Cell Non-Hodgkin Lymphoma
Hodgkin Lymphoma
Intervention:
Biological: CART-45 cells
Recruitment Status: Not recruiting
Phase: Phase 1
Date of First Enrollment: April 2026
Target Sample Size: 42
To know more, visit https://clinicaltrials.gov/study/NCT07451054
Published by HT Digital Co...